AAAAAA
Results:
1-12
|
Results: 12
Authors:
STOLZ B
WECKBECKER G
SMITHJONES PM
ALBERT R
RAULF F
BRUNS C
Citation: B. Stolz et al., THE SOMATOSTATIN RECEPTOR-TARGETED RADIOTHERAPEUTIC [Y-90-DOTA-DPHE(1),TYR(3)]OCTREOTIDE (Y-90-SMT-487) ERADICATES EXPERIMENTAL RAT PANCREATIC CA-20948 TUMORS, European journal of nuclear medicine, 25(7), 1998, pp. 668-674
Authors:
WECKBECKER G
PALLY C
RAULF F
BECKMANN N
SCHUURMAN JH
RUDIN M
BRUNS C
Citation: G. Weckbecker et al., THE SOMATOSTATIN ANALOG OCTREOTIDE AS POTENTIAL TREATMENT FOR RESTENOSIS AND CHRONIC REJECTION, Transplantation proceedings, 29(6), 1997, pp. 2599-2600
Authors:
JAMES RA
SARAPURA VD
BRUNS C
RAULF F
DOWDING JM
GORDON DF
WOOD WM
RIDGWAY EC
Citation: Ra. James et al., THYROID HORMONE-INDUCED EXPRESSION OF SPECIFIC SOMATOSTATIN RECEPTOR SUBTYPES CORRELATES WITH INVOLUTION OF THE TTT-97 MURINE THYROTROPE TUMOR, Endocrinology, 138(2), 1997, pp. 719-724
Authors:
SCHLOOS J
RAULF F
HOYER D
BRUNS C
Citation: J. Schloos et al., IDENTIFICATION AND PHARMACOLOGICAL CHARACTERIZATION OF SOMATOSTATIN RECEPTORS IN RAT LUNG, British Journal of Pharmacology, 121(5), 1997, pp. 963-971
Authors:
BRUNS C
RAULF F
HOYER D
SCHLOOS J
LUBBERT H
WECKBECKER G
Citation: C. Bruns et al., BINDING-PROPERTIES OF SOMATOSTATIN RECEPTOR SUBTYPES, Metabolism, clinical and experimental, 45(8), 1996, pp. 17-20
POTENTIATION OF THE ANTIPROLIFERATIVE EFFECTS OF ANTICANCER DRUGS BY OCTREOTIDE IN-VITRO AND IN-VIVO
Authors:
WECKBECKER G
RAULF F
TOLCSVAI L
BRUNS C
Citation: G. Weckbecker et al., POTENTIATION OF THE ANTIPROLIFERATIVE EFFECTS OF ANTICANCER DRUGS BY OCTREOTIDE IN-VITRO AND IN-VIVO, Digestion, 57, 1996, pp. 22-28
Authors:
KAUPMANN K
BRUNS C
RAULF F
WEBER HP
MATTES H
LUBBERT H
Citation: K. Kaupmann et al., 2 AMINO-ACIDS, LOCATED IN TRANSMEMBRANE DOMAIN-VI AND DOMAIN-VII, DETERMINE THE SELECTIVITY OF THE PEPTIDE AGONIST SMS-201-995 FOR THE SSTR2 SOMATOSTATIN RECEPTOR, EMBO journal, 14(4), 1995, pp. 727-735
Authors:
SCHLOOS J
RAULF F
HOYER D
ENGEL G
BRUNS C
Citation: J. Schloos et al., IDENTIFICATION AND CHARACTERIZATION OF SOMATOSTATIN RECEPTORS EXPRESSED IN RAT LUNG-TISSUE, British Journal of Pharmacology, 114, 1995, pp. 49-49
Authors:
GOTZ R
KOSTER R
WINKLER C
RAULF F
LOTTSPEICH F
SCHARTL M
THOENEN H
Citation: R. Gotz et al., NEUROTROPHIN-6 IS A NEW MEMBER OF THE NERVE GROWTH-FACTOR FAMILY, Nature, 372(6503), 1994, pp. 266-269
Authors:
RAULF F
PEREZ J
HOYER D
BRUNS C
Citation: F. Raulf et al., DIFFERENTIAL EXPRESSION OF 5 SOMATOSTATIN RECEPTOR SUBTYPES, SSTR1-5,IN THE CNS AND PERIPHERAL TISSUE, Digestion, 55, 1994, pp. 46-53
Authors:
WECKBECKER G
RAULF F
STOLZ B
BRUNS C
Citation: G. Weckbecker et al., SOMATOSTATIN ANALOGS FOR DIAGNOSIS AND TREATMENT OF CANCER, Pharmacology & therapeutics, 60(2), 1993, pp. 245-264
Authors:
ROHRER L
RAULF F
BRUNS C
BUETTNER R
HOFSTAEDTER F
SCHULE R
Citation: L. Rohrer et al., CLONING AND CHARACTERIZATION OF A 4TH HUMAN SOMATOSTATIN RECEPTOR, Proceedings of the National Academy of Sciences of the United Statesof America, 90(9), 1993, pp. 4196-4200
Risultati:
1-12
|